Pharma giant AstraZeneca agrees $2.7bn deal for United States firm ZS Pharma
Drug giant AstraZeneca (LON:AZN) has unveiled a US$2.7bn takeover bid for U.S. drug developer ZS Pharma, marking the latest move in a wave of M&A in the sector.
Posted On Nov 06 2015